Literature DB >> 23902487

Person-to-person spread of the MERS coronavirus--an evolving picture.

Stanley Perlman, Paul B McCray.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23902487     DOI： 10.1056/NEJMe1308724

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection.

Authors:  Kristen E Pascal; Christopher M Coleman; Alejandro O Mujica; Vishal Kamat; Ashok Badithe; Jeanette Fairhurst; Charleen Hunt; John Strein; Alexander Berrebi; Jeanne M Sisk; Krystal L Matthews; Robert Babb; Gang Chen; Ka-Man V Lai; Tammy T Huang; William Olson; George D Yancopoulos; Neil Stahl; Matthew B Frieman; Christos A Kyratsous
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

2.  Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.

Authors:  Kun Li; Christine L Wohlford-Lenane; Rudragouda Channappanavar; Jung-Eun Park; James T Earnest; Thomas B Bair; Amber M Bates; Kim A Brogden; Heather A Flaherty; Tom Gallagher; David K Meyerholz; Stanley Perlman; Paul B McCray
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

3.  New methodologies for the estimation of population vulnerability to diseases: a case study of Lassa fever and Ebola in Nigeria and Sierra Leone.

Authors:  Olumayowa Kajero; Victor Del Rio Vilas; James L N Wood; Giovanni Lo Iacono
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-08       Impact factor: 6.237

4.  Exportations of Symptomatic Cases of MERS-CoV Infection to Countries outside the Middle East.

Authors:  Cristina Carias; Justin J O'Hagan; Amy Jewett; Manoj Gambhir; Nicole J Cohen; Yoni Haber; Nicki Pesik; David L Swerdlow
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

5.  Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.

Authors:  Rudragouda Channappanavar; Lu Lu; Shuai Xia; Lanying Du; David K Meyerholz; Stanley Perlman; Shibo Jiang
Journal:  J Infect Dis       Date:  2015-06-08       Impact factor: 5.226

Review 6.  Institutional Preparedness to Prevent Future Middle East Respiratory Syndrome Coronavirus-Like Outbreaks in Republic of Korea.

Authors:  Min Huok Jeon; Tae Hyong Kim
Journal:  Infect Chemother       Date:  2016-06-30

7.  Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.

Authors:  Ahmed A Al-Qahtani; Konstantina Lyroni; Marina Aznaourova; Melpomeni Tseliou; Mashael R Al-Anazi; Mohammed N Al-Ahdal; Saad Alkahtani; George Sourvinos; Christos Tsatsanis
Journal:  Oncotarget       Date:  2017-02-07

8.  Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study.

Authors:  Fadilah Sfouq Aleanizy; Nahla Mohmed; Fulwah Y Alqahtani; Rania Ali El Hadi Mohamed
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

9.  Improved Global Capacity for Influenza Surveillance.

Authors:  Lauren S Polansky; Sajata Outin-Blenman; Ann C Moen
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

10.  Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome.

Authors:  David K Meyerholz; Allyn M Lambertz; Paul B McCray
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.